These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23876601)

  • 1. Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.
    Zhen C; Wang YL
    J Mol Diagn; 2013 Sep; 15(5):556-64. PubMed ID: 23876601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia.
    Press RD; Kamel-Reid S; Ang D
    J Mol Diagn; 2013 Sep; 15(5):565-76. PubMed ID: 23810242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
    Balasubramanian P; Chendamarai E; Markose P; Fletcher L; Branford S; George B; Mathews V; Chandy M; Srivastava A
    Acta Haematol; 2012; 127(3):135-42. PubMed ID: 22249155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
    Griffiths M; Patton SJ; Grossi A; Clark J; Paz MF; Labourier E;
    Arch Pathol Lab Med; 2015 Apr; 139(4):522-9. PubMed ID: 25061833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners.
    Akard LP; Wang YL
    Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):385-95. PubMed ID: 21723805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia.
    Soverini S; Branford S; Nicolini FE; Talpaz M; Deininger MW; Martinelli G; Müller MC; Radich JP; Shah NP
    Leuk Res; 2014 Jan; 38(1):10-20. PubMed ID: 24131888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices.
    Arora R; Press RD
    Leuk Lymphoma; 2017 Jan; 58(1):8-16. PubMed ID: 27412040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization.
    Cross NC; Hochhaus A; Müller MC
    Ann Hematol; 2015 Apr; 94 Suppl 2():S219-25. PubMed ID: 25814088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR].
    Larripa I; Ruiz MS; Gutiérrez M; Bianchini M
    Medicina (B Aires); 2017; 77(1):61-72. PubMed ID: 28140313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia.
    Moore FR; Rempfer CB; Press RD
    Methods Mol Biol; 2013; 999():1-23. PubMed ID: 23666687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the challenge in measuring and standardizing BCR-ABL1.
    Yu S; Cui M; He X; Jing R; Wang H
    Clin Chem Lab Med; 2017 Aug; 55(10):1465-1473. PubMed ID: 28222016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep molecular response in chronic myeloid leukemia: the new goal of therapy?
    Mahon FX; Etienne G
    Clin Cancer Res; 2014 Jan; 20(2):310-22. PubMed ID: 24166905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
    Moore FR; Yang F; Press RD
    Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.
    Jennings LJ; George D; Czech J; Yu M; Joseph L
    J Mol Diagn; 2014 Mar; 16(2):174-9. PubMed ID: 24389534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia].
    Beránek M; Voglová J; Sýkorová A; Belada D; Bláha M
    Cas Lek Cesk; 2006; 145(1):25-9; discussion 29-30. PubMed ID: 16468238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
    White HE; Hedges J; Bendit I; Branford S; Colomer D; Hochhaus A; Hughes T; Kamel-Reid S; Kim DW; Modur V; Müller MC; Pagnano KB; Pane F; Radich J; Cross NC; Labourier E
    Clin Chem; 2013 Jun; 59(6):938-48. PubMed ID: 23471097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?
    Qin YZ; Jiang Q; Jiang H; Li JL; Li LD; Zhu HH; Lai YY; Lu XJ; Liu YR; Jiang B; Huang XJ
    Leuk Res; 2013 Sep; 37(9):1035-40. PubMed ID: 23810191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach for BCR-ABL1 standardization to improve International Scale estimation.
    Maes B; Bakkus M; Boeckx N; Boone E; Cauwelier B; Denys B; De Schouwer P; Devos T; El Housni H; Hillen F; Jacobs K; Lambert F; Louagie H; Maes MB; Meeus P; Moreau E; Nollet F; Peeters K; Saussoy P; Van Lint P; Vaerman JL; Vaeyens F; Vandepoele K; Vannuffel P; Ver Elst K; Vermeulen K; Bruyndonckx R;
    Int J Lab Hematol; 2016 Dec; 38(6):674-684. PubMed ID: 27460189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ten years of molecular monitoring of chronic myeloid leukemia by quantitative RT-PCR].
    Moravcová J; Brdicka R
    Cas Lek Cesk; 2005; 144(1):32-7. PubMed ID: 15789779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML.
    Na IK; Kreuzer KA; Lupberger J; Dörken B; le Coutre P
    Leuk Res; 2005 Mar; 29(3):343-5. PubMed ID: 15661271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.